The course of COVID-19 in patients with severe asthma receiving biological treatment
Conclusion: Severe asthma itself seems to be a risk factor for COVID-19, whether biological treatment has a role in the disease course needs further research.PMID:34669544 | DOI:10.1080/02770903.2021.1996599
Source: Journal of Asthma - Category: Respiratory Medicine Authors: G ülseren Tuncay Mehmet Erdem Cakmak Ozge Can Bostan Saltuk Bugra Kaya Ebru Damadoglu G ül Karakaya Ali Fuat Kalyoncu Source Type: research
More News: Allergy | Allergy & Immunology | Asthma | Corticosteroid Therapy | COVID-19 | Middle East Health | Pandemics | Pneumonia | Respiratory Medicine | SARS | Study | Turkey Health | Xolair